Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Icosavax
2815 Eastlake Ave E, Suite 300
Seattle, WA 98102
http://www.icosavax.com/

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.

Key Contact
Name
Adam Simpson
Title
CEO
Funding Events

Date
Amount
Type
Investors
10/03/19 $51,000,000 Series A Adams Street Partners
NanoDimension
Qiming Venture Partners
Sanofi Ventures